The OPPA, a district branch of the American Psychiatric Association, is a statewide medical specialty organization whose more than 1,000 physician members specialize in the diagnosis, treatment and prevention of mental illnesses, including substance use disorders.

Subscribe to OPPA News BriefsLatest News


Why is it so hard to see a psychiatrist

Getting psychiatric care in the United States is a lot harder than it should be. Patients around the country are having a hard time booking appointments for outpatient care, and face significant hurdles when it comes to receiving inpatient psychiatric care. Why is this the case?


Telepsychiatry helps remote patients in SC

Increasingly, mental health organizations are using telehealth tools to treat patients with emotional and psychological disorders. Like the Veterans Health Administration (a longtime telehealth adopter), South Carolina's DMH uses telehealth to support mental health patients in 20 of the state's 65 hospitals' emergency departments and 17 mental health centers across 46 counties.


New study shows Rx restrictions hurt people

A new study administered by the National Council for Behavioral Health and the National Alliance on Mental Illness (NAMI) and published in Psychiatric Services today found many common insurance and state Medicaid policies may negatively impact patient health and impose a major workload on psychiatrists that takes time away from patient care and other important duties.


Medscape psychiatrist compensation report 2014

In case you missed it earlier this year, over 24,000 physicians in 25 specialties (7% or 1,680 of whom were psychiatrists) responded to this year's Medscape Compensation Report and described their 2013 compensation, number of hours worked, practice changes resulting from healthcare reform, and adaptations to the new healthcare environment.


APA e-Focus free CME: Misery Loves Company: Understanding the Evidence

Get started on the fifth of 10 clinical vignettes: Misery Loves Company: Understanding the Evidence Prescribing of atypical antipsychotics has expanded beyond the FDA approved indications, but their effectiveness, benefits, and adverse effects in off-label uses are not well understood. How do atypical antipsychotic medications compare with other drugs for "off-label" indications? This program can help!

View all

Subscribe to OPPA Upcoming EventsUpcoming Events

 December 2014 
January 5, 2015

OPPA Membership Committee


January 12, 2015

OPPA Government Relations Committee


View all